CHEMPIME-1.25

Product Description

CHEMPIME-1.25 is a combination antibiotic that contains Cefepime 1000mg and Tazobactam 125mg, designed to combat a wide range of bacterial infections. This potent formulation effectively targets both gram-positive and gram-negative bacteria, making it an essential choice for healthcare professionals in treating severe or resistant infections. Its ability to penetrate well into tissues and fluids contributes to its efficacy, ensuring that patients receive optimal therapeutic outcomes.

This product is often prescribed in hospital settings for conditions such as pneumonia, urinary tract infections, and intra-abdominal infections. The synergy between Cefepime and Tazobactam enhances its effectiveness, providing a robust defense against bacteria that produce beta-lactamase enzymes. As antibiotic resistance becomes a growing concern globally, CHEMPIME-1.25 represents a critical weapon in the medical arsenal against infectious diseases.

Dosage and Administration

The recommended dosage of CHEMPIME-1.25 varies based on the type and severity of the infection being treated. It is typically administered intravenously, allowing for rapid absorption and action within the body. Healthcare providers will determine the appropriate dosage for each patient, taking into consideration factors such as body weight, renal function, and the specific bacterial strain involved.